![]() Orexo Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs. | ![]() Active Biotech Active Biotech is a biotechnology company with a focus on neurodegenerative and inflammatory diseases and cancer. | Imvax Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers. | |
Founding Date | Founding Date 1995 | Founding Date 1998 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Uppsala, SE HQ Uppsala, SE Morristown, US | Locations Lund, SE HQ Lund, SE | Locations Philadelphia, US HQ |
Employees | Employees 110 | Employees 517% decrease | Employees 2723% decrease |
Valuation ($) | Valuation ($) 36.3 m | Valuation ($) 21 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) kr26m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods kr14.5m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr18m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (kr403.3m) (FY, 2025) | Net income (kr37.3m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 72.9m | Total funding raised N/A | Total funding raised $ 166.7m |

Active Biotech is a biotechnology company with a focus on neurodegenerative and inflammatory diseases and cancer.
View companyImvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers.
View company